Literature DB >> 29383636

The dark side of the kidney in cardio-renal syndrome: renal venous hypertension and congestive kidney failure.

Pierpaolo Di Nicolò1.   

Abstract

Renal involvement in some forms of acute or chronic diseases, such as heart failure or sepsis, presents with a complex pathophysiological basis that is not always clearly distinguishable. In these clinical settings, kidney failure is traditionally and almost exclusively attributed to renal hypoperfusion and it is commonly accepted that causal elements are pre-renal, such as a reduction in the ejection fraction or absolute or relative hypovolemia acting directly on oxygen transport mechanisms and renal autoregulation systems, causing a reduction of glomerular filtration rate. Nevertheless, the concept emerging from accumulating clinical and experimental evidence is that in complex clinical pictures, kidney failure is strongly linked to the hemodynamic alterations occurring in the renal venous micro and macrocirculation. Accordingly, the transmission of the increased venous pressure to the renal venous compartment and the consequent increasing renal afterload has a pivotal role in determining and sustaining the kidney damage. The aim of this review was to clarify the physiopathological aspects of the link between worsening renal function and renal venous hypertension, analyzing the prognostic and therapeutic implications of the so-called congestive kidney failure in cardio-renal syndrome and in other clinical contexts of its possible onset.

Entities:  

Keywords:  Acute kidney injury; Cardio-renal syndrome; Congestive kidney; Heart failure; Renal venous hypertension

Mesh:

Year:  2018        PMID: 29383636     DOI: 10.1007/s10741-018-9673-4

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  98 in total

1.  Mechanism of impaired natriuretic response to furosemide during prolonged therapy.

Authors:  N R Loon; C S Wilcox; R J Unwin
Journal:  Kidney Int       Date:  1989-10       Impact factor: 10.612

Review 2.  Regulation of sodium excretion by renal interstitial hydrostatic pressure.

Authors:  J P Granger
Journal:  Fed Proc       Date:  1986-12

Review 3.  Prognostic significance of adrenomedullin in patients with heart failure and with myocardial infarction.

Authors:  Matthew F Yuyun; Hafid K Narayan; Leong L Ng
Journal:  Am J Cardiol       Date:  2015-01-15       Impact factor: 2.778

4.  Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.

Authors:  Bernard Cholley; Thibaut Caruba; Sandrine Grosjean; Julien Amour; Alexandre Ouattara; Judith Villacorta; Bertrand Miguet; Patrick Guinet; François Lévy; Pierre Squara; Nora Aït Hamou; Aude Carillion; Julie Boyer; Marie-Fazia Boughenou; Sebastien Rosier; Emmanuel Robin; Mihail Radutoiu; Michel Durand; Catherine Guidon; Olivier Desebbe; Anaïs Charles-Nelson; Philippe Menasché; Bertrand Rozec; Claude Girard; Jean-Luc Fellahi; Romain Pirracchio; Gilles Chatellier
Journal:  JAMA       Date:  2017-08-08       Impact factor: 56.272

5.  Diuretic strategies in patients with acute decompensated heart failure.

Authors:  G Michael Felker; Kerry L Lee; David A Bull; Margaret M Redfield; Lynne W Stevenson; Steven R Goldsmith; Martin M LeWinter; Anita Deswal; Jean L Rouleau; Elizabeth O Ofili; Kevin J Anstrom; Adrian F Hernandez; Steven E McNulty; Eric J Velazquez; Abdallah G Kfoury; Horng H Chen; Michael M Givertz; Marc J Semigran; Bradley A Bart; Alice M Mascette; Eugene Braunwald; Christopher M O'Connor
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

6.  Effects of adrenomedullin on angiotensin II stimulated atrial natriuretic peptide and arginine vasopressin secretion in healthy humans.

Authors:  M C Petrie; J E McDonald; C Hillier; J J Morton; J J McMurray
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

Review 7.  Intravenous Fluids and Acute Kidney Injury.

Authors:  Xiaoqiang Ding; Zhen Cheng; Qi Qian
Journal:  Blood Purif       Date:  2017-01-24       Impact factor: 2.614

Review 8.  ROSE-AHF and lessons learned.

Authors:  Amit K Jain; Horng H Chen
Journal:  Curr Heart Fail Rep       Date:  2014-09

9.  Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure.

Authors:  M E Leithe; R D Margorien; J B Hermiller; D V Unverferth; C V Leier
Journal:  Circulation       Date:  1984-01       Impact factor: 29.690

10.  Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction.

Authors:  Kevin Damman; Gerjan Navis; Tom D J Smilde; Adriaan A Voors; Wim van der Bij; Dirk J van Veldhuisen; Hans L Hillege
Journal:  Eur J Heart Fail       Date:  2007-06-22       Impact factor: 15.534

View more
  4 in total

Review 1.  Renal intraparenchymal resistive index: the ultrasonographic answer to many clinical questions.

Authors:  Pierpaolo Di Nicolò; Antonio Granata
Journal:  J Nephrol       Date:  2018-12-11       Impact factor: 3.902

2.  What's new in ultrasound-based assessment of organ perfusion in the critically ill: expanding the bedside clinical monitoring window for hypoperfusion in shock.

Authors:  Francesco Corradi; Gabriele Via; Guido Tavazzi
Journal:  Intensive Care Med       Date:  2019-10-25       Impact factor: 17.440

3.  Association between central haemodynamics and renal function in advanced heart failure: a nationwide study from Sweden.

Authors:  Emanuele Bobbio; Entela Bollano; Christian L Polte; Jan Ekelund; Göran Rådegran; Jakob Lundgren; Carl Haggård; Grunde Gjesdal; Oscar Braun; Sven-Erik Bartfay; Niklas Bergh; Pia Dahlberg; Clara Hjalmarsson; Sorosh Esmaily; Ida Haugen Löfman; Aristomenis Manouras; Michael Melin; Göran Dellgren; Kristjan Karason
Journal:  ESC Heart Fail       Date:  2022-05-25

4.  Effects of High-Flux Dialysis Combined with Hemoperfusion on Serum GRP78 and miR-495-3p in Renal Failure Patients.

Authors:  Wei Fan; Xudong Li; Xiangjun Xu; Hong Chu
Journal:  Biomed Res Int       Date:  2021-10-11       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.